Biomarkers Market Research Reports & Industry Analysis
Biomarkers are measurable indicators, such as molecules or genetic mutations, that provide information about a biological process, condition, or disease in the body. As healthcare evolves, it's important to grasp the impact and unique dynamics of this industry. At MarketResearch.com, we understand the need for reliable data on this sector. Our biomarkers market research reports provide a comprehensive and informative analysis, empowering you to navigate this dynamic industry with greater confidence.
Biomarkers Industry Insights
- Our research covers diverse markets so you can quickly and easily find research on segments big and small.
- Through our platform, you can access essential data to drive strategic decisions, from biomarkers market sizing and growth projections to key drivers and challenges.
- Use our research to better understand products under development, market trends, competitor analysis, and leading players.
Harnessing MarketResearch.com's Expertise
For more than twenty years, MarketResearch.com has been a leader in the field of market research, serving a diverse clientele that includes top investment banks, management consulting firms, and multinational corporations. We are known for providing reliable insights and offer a centralized platform with access to reports from numerous firms. In addition, our research specialists are available to provide expert guidance and support every step of the way.
Biomarkers Industry Research & Market Reports
-
Multiple Myeloma Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Smoldering (indolent) Multiple Myeloma, Active (Symptomatic) Multiple Myeloma); By Treatment (Chemotherapy, Targeted Therapy, Immunomodulatory Drugs, Steroids, Bone-Modifying Drugs, Immunotherapy, Bone Marrow/Stem Cell Transplantation, Radiation Therapy, Surgery); By Diagnosis (Blood & Urine Tests, X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT/CAT) Scan, Positron Emission Tomography (PET)/ PET-CT Scan, Bone Marrow Aspiration & Biopsy, Fat Pad Aspirate, Biomarker Testing of the Tumor); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Immunotherapy, Bone Marrow/Stem Cell Transplantation, Radiation Therapy, Surgery); By Diagnosis (Blood & Urine Tests, X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT/CAT) Scan, Positron Emission Tomography (PET)/ PET-CT Scan, Bone Marrow Aspiration & Biopsy, Fat ... Read More
-
Central Nervous System (CNS) Biomarker Market Outlook to 2030- Forecasts of Market Size, Share, Companies, Countries, Trends, Opportunities, and Industry Developments Report
... the market size poised to register an optimistic growth between 2024 and 2030. Robust demand from end-user industries, widening applications, and investments in new technologies support the long-term market growth potential. The late-2023 edition- “Central ... Read More
-
Canada Clinical Biomarkers Market by Product (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), By Services (Genomic Biomarker Service, Tissue Biomarker Service, Cell Service, Proteomics Service), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Others), By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Others), By Application (Translational Research v/s Clinical Diagnostics), By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Academic & Research Institutions, Others), By Region and Competition, Forecast & Opportunities, 2018-2028F
... Assay, Others), By Clinical Area (Cancer Biomarker, Cardiac Biomarker, Neurological Biomarker, Infectious Disease Biomarker, Others), By Application (Translational Research v/s Clinical Diagnostics), By End User (Biotechnology & Pharmaceutical Companies, Diagnostic Centers, Academic & Research Institutions, ... Read More
-
Artificial Blood Vessels Market – Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 Segmented By Application (Aortic Disease, Peripheral Artery Disease, Haemodialysis), By Polymer (Polydioxanone, Elastomer, Polyethylene Terephthalate, Others), By Region, Competition
... with an anticipated Compound Annual Growth Rate (CAGR) of 5.11% through 2028. This market represents a dynamic and rapidly evolving sector within the healthcare industry, driven by several converging factors that emphasize the urgency and ... Read More
-
Proteomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Reagents & Assays, Instruments, Software & Services), By Technology (Spectroscopy, Microarray instruments, Chromatography, X-ray crystallography, Protein Microarrays, Electrophoresis), By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others), By Type (Expression, Functional, Structural, Computational), By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs), By Region and Competition
... period with a CAGR of 4.56% through 2028. Real-time polymerase chain reactions (PCR) are molecular biology laboratory techniques that build upon the principles of PCR. In the fields of clinical and veterinary diagnostics, as well ... Read More
-
2023-2027 Uruguay Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Europe Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - France, Germany, Italy, Spain, UK - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities This new 5-country report from LeadingMarketResearch.com This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ... Read More
-
2023-2027 Panama Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Kazakhstan Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 U.S. Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
2023-2027 Qatar Breast Cancer Diagnostics Market - CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor - Country Database and Analysis - Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities
... Emerging Technologies, Latest Instrumentation, Growth Opportunities This new report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding breast ... Read More
-
Next-Generation Gynecological Cancer Diagnostics Global Market Report 2023 Including: 1) By Cancer Type: Cervical Cancer; Ovarian Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer 2) By Function: Therapeutic Monitoring; Companion Diagnostics; Prognostics; Cancer Screening; Risk Analysis 3) By Technology: Next-Generation Sequencing; qPCR And Multiplexing; Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR); Protein Microarrays; DNA Microarrays 4) By Application: Biomarker Development; CTC Analysis; Proteomic Analysis; Epigenetic Analysis; Genetic Analysis 5) By End User: Hospitals and Ambulatory Centers; Diagnostic Laboratories; Academic and Research Institutes Covering: F. Hoffmann-La Roche Ltd.; AbbVie Inc.; Novartis AG; Thermo Fisher Scientific Inc.; Abbott Laboratories
... Technology: Next-Generation Sequencing; qPCR And Multiplexing; Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR); Protein Microarrays; DNA Microarrays4) By Application: Biomarker Development; CTC Analysis; Proteomic Analysis; Epigenetic Analysis; Genetic Analysis5) By End User: Hospitals and ... Read More
-
Cardiac Markers Rapid Tests and POC Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
... Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Cardiac Markers Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of ... Read More
-
Cancer/Tumor Profiling Market by Biomarker Type (Genetic, Protein) Technology (NGS, PCR, ISH, IHC) Cancer Type (Breast, Lung, Colorectal, Prostate, Leukemia) Application (Clinical, Research) End User (Pharma, Academic, CRO) - Global Forecast to 2030
... market is projected to reach $22.3 billion by 2030, at a CAGR of 20.9% from 2023 to 2030. Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the ... Read More
-
Global Cancer Profiling Market Size study & Forecast, by Technology (Immunoassays, Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays, and Others), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, and Others), Biomarker Type (Genetic Biomarkers, Protein Biomarkers, and Others), and Regional Analysis, 2023-2030
... (Genetic Biomarkers, Protein Biomarkers, and Others), and Regional Analysis, 2023-2030 Global Cancer Profiling Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global PD-L1 Biomarker Testing Market (2023 Edition): Analysis By Cancer Type (NSCLC, Kidney Cancer, Melanoma, Head and Neck, Bladder Cancer, Others), Assay Kit Type, End Use, By Region, By Country: Market Insights and Forecast (2019-2029)
... Executive Summary Azoth Analytics has released a research report titled “Global PD-L1 Biomarker Testing Market (2023 Edition)” which provides a complete analysis of the global PD-L1 Biomarker Testing industry in terms of market segmentation by ... Read More
-
Imaging Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
... development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets. The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The ... Read More
-
Veterinary Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Animal Type (Companion Animals, Production Animals); By Product Type; By Application; By Disease Type; By Region, And Segment Forecasts, 2023 - 2032
... biomarkers market size is expected to reach USD 2,554.79 million by 2032, according to a new study by Polaris Market Research. The report “Veterinary Biomarkers Market Share, Size, Trends, Industry Analysis Report, By Animal Type ... Read More
-
Global Cardiac Marker Analyzer Market, By Region and Country, Product Analysis, Key Company’s Business & Marketing Strategy, Major Deals, Recent Developments – Forecast to 2028
... US$ 1,120 Million by 2028. Cardiac marker analyzer provides high-quality point-of-care testing solutions used to diagnose heart diseases such as myocardial infarction and other cardiac-related diseases. These devices measure the levels of enzymes and proteins ... Read More
-
Cancer Biomarkers Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2028, at a CAGR of 12.43% during the forecast period (2023-2028). The COVID-19 pandemic had an adverse impact on the cancer biomarkers market owing to the interrupted research and development activities during this period. For ... Read More
-
Liquid Biopsy Market - Global Liquid Biopsy Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 (By Biomarker, By Source, By Clinical Application, By Indication, By Geographic Coverage and By Company)
... biopsy market is set for a phenomenal rise, offering a cutting-edge approach to early cancer detection, and transforming the landscape of cancer diagnostics. According to a comprehensive growth analysis conducted by Fairfield Market Research, the ... Read More
-
Technology Advances and Growth Opportunities in Elderly Care
... years of age or more. The aged population will likely increase from 1 billion in 2020 to 1.4 billion in 2030 and 2.1 billion by 2050. The senior population typically experiences a gradual decrease in ... Read More
-
Cardiac Biomarkers Testing Devices - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
... Myoglobin, and Others]), Application (Acute Coronary Syndrome, Congestive Heart Failure, Myocardial Infarction, and Others), End-User (Hospitals, Pathology Labs, and Others), and Geography is expected to grow at a steady CAGR forecast till 2028 owing to ... Read More
-
Global Oncology Diagnostics in IVD Growth Opportunities
... expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, ... Read More
-
MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets
... strategic recommendations for the success of the market participants. This study focuses on the global market of miRNA tools and provides an updated review including its applications in various arenas of diagnostics and therapeutics. The ... Read More